Atherosclerosis and sex hormones: Current concepts

Clinical Science

Volumn 119, Issue 12, 2010, Pages 493-513

  Villablanca, Amparo C ^a   Jayachandran, Muthuvel ^b   Banka, Carole ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Mayo Clinic   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Androgen; Atherosclerosis; Cardiovascular disease; Cell type; Gender; Oestrogen; Progesterone

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GESTAGEN; PROGESTERONE RECEPTOR;

ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; CORONARY RISK; ENDOTHELIUM; HUMAN; HUMAN CELL; INFLAMMATION; LIPOPROTEIN METABOLISM; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SEX DIFFERENCE; SMOOTH MUSCLE FIBER; TISSUE SPECIFICITY;

ANIMALS; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; ENDOTHELIUM, VASCULAR; FEMALE; GONADAL STEROID HORMONES; HUMANS; INFLAMMATION; MACROPHAGES; MALE; MUSCLE, SMOOTH, VASCULAR; RECEPTORS, STEROID; SEX CHARACTERISTICS;

EID: 78649862146     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20100248     Document Type: Review

References (208)

1. Lethbridge-Cejku, M., Schiller, J. S. and Bernadel, L. (2004) Summary health statistics for U.S. adults: National Health Interview Survey, 2002. Vital Health Stat. 10, 1-151
2. Rosamond, W., Flegal, K., Furie, K., Go, A., Greenlund, K., Haase, N., Hailpern, S. M., Ho, M., Howard, V., Kissela, B. et al. (2008) Heart disease and stroke statistics - 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117, e25-e146
3. Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, Jr, J. L., Jones, D. W., Materson, B. J., Oparil, S., Wright, Jr, J. T. and Roccella, E. J. (2003) Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42, 1206-1252
4. Christian, A. H., Rosamond, W., White, A. R. and Mosca, L. (2007) Nine-year trends and racial and ethnic disparities in women's awareness of heart disease and stroke: an American Heart Association national study. J. Womens Health 16, 68-81
5. Goff, Jr, D. C., Mitchell, P., Finnegan, J., Pandey, D., Bittner, V., Feldman, H., Meischke, H., Goldberg, R. J., Luepker, R. V., Raczynski, J. M. et al. (2004) Knowledge of heart attack symptoms in 20 US communities. Results from the Rapid Early Action for Coronary Treatment Community Trial. Prev. Med. 38, 85-93
6. Mosca, L., Grundy, S. M., Judelson, D., King, K., Limacher, M., Oparil, S., Pasternak, R., Pearson, T. A., Redberg, R. F., Smith, Jr, S. C. et al. (1999) Guide to Preventive Cardiology for Women. AHA/ACC Scientific Statement Consensus panel statement. Circulation 99, 2480-2484.
7. Mosca, L., Ferris, A., Fabunmi, R. and Robertson, R. M. (2004) Tracking women's awareness of heart disease: an American Heart Association national study. Circulation 109, 573-579
8. Mosca, L., Mochari, H., Christian, A., Berra, K., Taubert, K., Mills, T., Burdick, K. A. and Simpson, S. L. (2006) National study of women's awareness, preventive action, and barriers to cardiovascular health. Circulation 113, 525-534
9. Mosca, L., Appel, L. J., Benjamin, E. J., Berra, K., Chandra-Strobos, N., Fabunmi, R. P., Grady, D., Haan, C. K., Hayes, S. N., Judelson, D. R. et al. (2004) Evidence-based guidelines for cardiovascular disease prevention in women. Circulation 109, 672-693 (Pubitemid 38198877)
10. Mosca, L., Banka, C. L., Benjamin, E. J., Berra, K., Bushnell, C., Dolor, R. J., Ganiats, T. G., Gomes, A. S., Gornik, H. L., Gracia, C. et al. (2007) Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation 115, 1481-1501 (Pubitemid 46648385)
11. Schoenhagen, P., Nissen, S. E. and Tuzcu, E. M. (2003) Coronary arterial remodeling: from bench to bedside. Curr. Atheroscler. Rep. 5, 150-154
12. Mendelsohn, M. E. and Karas, R. H. (1999) The protective effects of estrogen on the cardiovascular system. N. Engl. J. Med. 340, 1801-1811
13. Nabulsi, A. A., Folsom, A. R., White, A., Patsch, W., Heiss, G., Wu, K. K. and Szklo, M. (1993) Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. N. Engl. J. Med. 328, 1069-1075
14. Stampfer, M. J., Colditz, G. A., Willett, W. C., Manson, J. E., Rosner, B., Speizer, F. E. and Hennekens, C. H. (1991) Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study. N. Engl. J. Med. 325, 756-62
15. Rifici, V. A. and Khachadurian, A. K. (1992) The inhibition of low-density lipoprotein oxidation by 17-β estradiol. Metab. Clin. Exp. 41, 1110-1114
16. Sack, M. N., Rader, D. J. and Cannon, III, R. O. (1994) Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women. Lancet 343, 269-270
17. Hong, M. K., Romm, P. A., Reagan, K., Green, C. E. and Rackley, C. E. (1992) Effects of estrogen replacement therapy on serum lipid values and angiographically defined coronary artery disease in postmenopausal women. Am. J. Cardiol. 69, 176-178
18. Fogelberg, M., Vesterqvist, O., Diczfalusy, U. and Henriksson, P. (1990) Experimental atherosclerosis: effects of oestrogen and atherosclerosis on thromboxane and prostacyclin formation. Eur. J. Clin. Invest. 20, 105-110
19. Mikkola, T., Turunen, P., Avela, K., Orpana, A., Viinikka, L. and Ylikorkala, O. (1995) 17β-estradiol stimulates prostacyclin, but not endothelin-1, production in human vascular endothelial cells. J. Clin. Endocrinol. Metab. 80, 1832-1836
20. Weiner, C. P., Lizasoain, I., Baylis, S. A., Knowles, R. G., Charles, I. G. and Moncada, S. (1994) Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc. Natl. Acad. Sci. U.S.A. 91, 5212-5216
21. Rossouw, J. E., Anderson, G. L., Prentice, R. L., LaCroix, A. Z., Kooperberg, C., Stefanick, M. L., Jackson, R. D., Beresford, S. A., Howard, B. V., Johnson, K. C. et al. (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA, J. Am. Med. Assoc. 288, 321-333
22. Anderson, G. L., Limacher, M., Assaf, A. R., Bassford, T., Beresford, S. A., Black, H., Bonds, D., Brunner, R., Brzyski, R., Caan, B. et al. (2004) Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA, J. Am. Med. Assoc. 291, 1701-1712
23. Hulley, S., Grady, D., Bush, T., Furberg, C., Herrington, D., Riggs, B. and Vittinghoff, E. (1998) Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA, J. Am. Med. Assoc. 280, 605-613
24. Grodstein, F., Manson, J. E. and Stampfer, M. J. (2006) Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation. J. Womens Health 15, 35-44 (Pubitemid 43192860)
25. Losordo, D. W., Kearney, M., Kim, E. A., Jekanowski, J. and Isner, J. M. (1994) Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. Circulation 89, 1501-1510
26. Dubey, R. K., Imthurn, B., Barton, M. and Jackson, E. K. (2005) Vascular consequences of menopause and hormone therapy: importance of timing of treatment and type of estrogen. Cardiovasc. Res. 66, 295-306
27. Straub, R. H. (2007) The complex role of estrogens in inflammation. Endocr. Rev. 28, 521-574
28. Herrington, D. M., Brosnihan, K. B., Pusser, B. E., Seely, E. W., Ridker, P. M., Rifai, N. and MacLean, D. B. (2001) Differential effects of E and droloxifene on C-reactive protein and other markers of inflammation in healthy postmenopausal women. J. Clin. Endocrinol. Metab. 86, 4216-4222
29. Silvestri, A., Gebara, O., Vitale, C., Wajngarten, M., Leonardo, F., Ramires, J. A., Fini, M., Mercuro, G. and Rosano, G. M. (2003) Increased levels of C-reactive protein after oral hormone replacement therapy may not be related to an increased inflammatory response. Circulation 107, 3165-3169
30. Ross, R. and Glomset, J. A. (1973) Atherosclerosis and the arterial smooth muscle cell: proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis. Science 180, 1332-1339
31. Ross, R. (1999) Atherosclerosis is an inflammatory disease. Am. Heart J. 138, S419-S420
32. Libby, P. (2006) Inflammation and cardiovascular disease mechanisms. Am. J. Clin. Nutr. 83, 456S-460S
33. Vasankari, T., Ahotupa, M., Toikka, J., Mikkola, J., Irjala, K., Pasanen, P., Neuvonen, K., Raitakari, O. and Viikari, J. (2001) Oxidized LDL and thickness of carotid intima-media are associated with coronary atherosclerosis in middle-aged men: lower levels of oxidized LDL with statin therapy. Atherosclerosis 155, 403-412
34. Libby, P. (2008) The molecular mechanisms of the thrombotic complications of atherosclerosis. J. Intern. Med. 263, 517-527
35. Lewis, J. F., McGorray, S. P. and Pepine, C. J. (2002) Assessment of women with suspected myocardial ischemia: review of findings of the Women's Ischemia Syndrome Evaluation (WISE) Study. Curr. Womens Health Rep. 2, 110-114
36. Hochman, J. S., Tamis, J. E., Thompson, T. D., Weaver, W. D., White, H. D., Van de Werf, F., Aylward, P., Topol, E. J. and Califf, R. M. (1999) Sex, clinical presentation, and outcome in patients with acute coronary syndromes. N. Engl. J. Med. 341, 226-32
37. Arbustini, E., Morbini, P., Bello, B. D., Prati, F. and Specchia, G. (1999) From plaque biology to clinical setting. Am. Heart J. 138, S55-S60
38. Bugiardini, R., Manfrini, O., Pizzi, C., Fontana, F. and Morgagni, G. (2004) Endothelial function predicts future development of coronary artery disease: a study of women with chest pain and normal coronary angiograms. Circulation 109, 2518-2523
39. Johnson, B. D., Shaw, L. J., Buchthal, S. D., Bairey Merz, C. N., Kim, H. W., Scott, K. N., Doyle, M., Olson, M. B., Pepine, C. J., den Hollander, J. et al. (2004) Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: results from the National Institutes of Health-National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation 109, 2993-2999
40. Halcox, J. P., Schenke, W. H., Zalos, G., Mincemoyer, R., Prasad, A., Waclawiw, M. A., Nour, K. R. and Quyyumi, A. A. (2002) Prognostic value of coronary vascular endothelial dysfunction. Circulation 106, 653-658
41. Chadwick, C. C., Chippari, S., Matelan, E., Borges-Marcucci, L., Eckert, A. M., Keith, Jr, J. C., Albert, L. M., Leathurby, Y., Harris, H. A., Bhat, R. A. et al. (2005) Identification of pathway-selective estrogen receptor ligands that inhibit NF-κB transcriptional activity. Proc. Natl. Acad. Sci. U.S.A. 102, 2543-2548
42. Speir, E., Yu, Z. X., Takeda, K., Ferrans, V. J. and Cannon, III, R. O. (2000) Competition for p300 regulates transcription by estrogen receptors and nuclear factor-κB in human coronary smooth muscle cells. Circ. Res. 87, 1006-1011
43. Pedram, A., Razandi, M., Sainson, R. C., Kim, J. K., Hughes, C. C. and Levin, E. R. (2007) A conserved mechanism for steroid receptor translocation to the plasma membrane. J. Biol. Chem. 282, 22278-22288
44. Revankar, C. M., Cimino, D. F., Sklar, L. A., Arterburn, J. B. and Prossnitz, E. R. (2005) A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 307, 1625-1630
45. Filardo, E., Quinn, J., Pang, Y., Graeber, C., Shaw, S., Dong, J. and Thomas, P. (2007) Activation of the novel estrogen receptor G protein-coupled receptor 30 (GPR30) at the plasma membrane. Endocrinology 148, 3236-3245
46. Maggiolini, M. and Picard, D. The unfolding stories of GPR30, a new membrane-bound estrogen receptor. J. Endocrinol. 204, 105-114
47. Zhu, Y., Bond, J. and Thomas, P. (2003) Identification, classification, and partial characterization of genes in humans and other vertebrates homologous to a fish membrane progestin receptor. Proc. Natl. Acad. Sci. U.S.A. 100, 2237-2242
48. Moggs, J. G. and Orphanides, G. (2001) Estrogen receptors: orchestrators of pleiotropic cellular responses. EMBO Rep. 2, 775-781
49. Chaidarun, S. S. and Alexander, J. M. (1998) A tumor-specific truncated estrogen receptor splice variant enhances estrogen-stimulated gene expression. Mol. Endocrinol. 12, 1355-1366
50. Chu, S. and Fuller, P. J. (1997) Identification of a splice variant of the rat estrogen receptor β gene. Mol. Cell. Endocrinol. 132, 195-199
51. Zhao, C., Dahlman-Wright, K. and Gustafsson, J. A. (2008) Estrogen receptor β: an overview and update. Nucl. Recept. Signaling 6, e003
52. Wang, J. M., Irwin, R. W. and Brinton, R. D. (2006) Activation of estrogen receptor α increases and estrogen receptor β decreases apolipoprotein E expression in hippocampus in vitro and in vivo. Proc. Natl. Acad. Sci. U.S.A. 103, 16983-16988
53. O'Lone, R., Knorr, K., Jaffe, I. Z., Schaffer, M. E., Martini, P. G., Karas, R. H., Bienkowska, J., Mendelsohn, M. E. and Hansen, U. (2007) Estrogen receptors α and β mediate distinct pathways of vascular gene expression, including genes involved in mitochondrial electron transport and generation of reactive oxygen species. Mol. Endocrinol. 21, 1281-1296
54. Li, X. and O'Malley, B. W. (2003) Unfolding the action of progesterone receptors. J. Biol. Chem. 278, 39261-39264
55. Lubahn, D. B., Joseph, D. R., Sullivan, P. M., Willard, H. F., French, F. S. and Wilson, E. M. (1988) Cloning of human androgen receptor complementary DNA and localization to the X chromosome. Science 240, 327-330
56. Okano, H., Jayachandran, M., Yoshikawa, A. and Miller, V. M. (2006) Differential effects of chronic treatment with estrogen receptor ligands on regulation of nitric oxide synthase in porcine aortic endothelial cells. J. Cardiovasc. Pharmacol. 47, 621-628
57. Demyanets, S., Pfaffenberger, S., Kaun, C., Rega, G., Speidl, W. S., Kastl, S. P., Weiss, T. W., Hohensinner, P. J., Dietrich, W., Tschugguel, W. et al. (2006) The estrogen metabolite 17β-dihydroequilenin counteracts interleukin-1α induced expression of inflammatory mediators in human endothelial cells in vitro via NF-κB pathway. Thromb. Haemostasis 95, 107-116
58. Toth, B., Saadat, G., Geller, A., Scholz, C., Schulze, S., Friese, K. and Jeschke, U. (2008) Human umbilical vascular endothelial cells express estrogen receptor β (ERβ) and progesterone receptor A (PR-A), but not ERα and PR-B. Histochem. Cell Biol. 130, 399-405
59. Dan, P., Cheung, J., Scriven, D. R. and Moore, E. D. (2003) Epitope-dependent localization of estrogen receptor-α, but not -β, in en face arterial endothelium. Am. J. Physiol. Heart Circ. Physiol. 284, H1295-H1306
60. Ihionkhan, C. E., Chambliss, K. L., Gibson, L. L., Hahner, L. D., Mendelsohn, M. E. and Shaul, P. W. (2002) Estrogen causes dynamic alterations in endothelial estrogen receptor expression. Circ. Res. 91, 814-820
61. Isensee, J., Meoli, L., Zazzu, V., Nabzdyk, C., Witt, H., Soewarto, D., Effertz, K., Fuchs, H., Gailus-Durner, V., Busch, D. et al. (2009) Expression pattern of G protein-coupled receptor 30 in LacZ reporter mice. Endocrinology 150, 1722-1730
62. Haas, E., Bhattacharya, I., Brailoiu, E., Damjanovic, M., Brailoiu, G. C., Gao, X., Mueller-Guerre, L., Marjon, N. A., Gut, A., Minotti, R. et al. (2009) Regulatory role of G protein-coupled estrogen receptor for vascular function and obesity. Circ. Res. 104, 288-291
63. Tatsumi, H., Kitawaki, J., Tanaka, K., Hosoda, T. and Honjo, H. (2002) Lack of stimulatory effect of dienogest on the expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 by endothelial cell as compared with other synthetic progestins. Maturitas 42, 287-294
64. Vazquez, F., Rodriguez-Manzaneque, J. C., Lydon, J. P., Edwards, D. P., O'Malley, B. W. and Iruela-Arispe, M. L. (1999) Progesterone regulates proliferation of endothelial cells. J. Biol. Chem. 274, 2185-2192
65. Hatakeyama, H., Nishizawa, M., Nakagawa, A., Nakano, S., Kigoshi, T. and Uchida, K. (2002) Testosterone inhibits tumor necrosis factor-α-induced vascular cell adhesion molecule-1 expression in human aortic endothelial cells. FEBS Lett. 530, 129-132
66. Norata, G. D., Tibolla, G., Seccomandi, P. M., Poletti, A. and Catapano, A. L. (2006) Dihydrotestosterone decreases tumor necrosis factor-α and lipopolysaccharide-induced inflammatory response in human endothelial cells. J. Clin. Endocrinol. Metab. 91, 546-554
67. Death, A. K., McGrath, K. C., Sader, M. A., Nakhla, S., Jessup, W., Handelsman, D. J. and Celermajer, D. S. (2004) Dihydrotestosterone promotes vascular cell adhesion molecule-1 expression in male human endothelial cells via a nuclear factor-κB-dependent pathway. Endocrinology 145, 1889-1897
68. Mukherjee, T. K., Dinh, H., Chaudhuri, G. and Nathan, L. (2002) Testosterone attenuates expression of vascular cell adhesion molecule-1 by conversion to estradiol by aromatase in endothelial cells: implications in atherosclerosis. Proc. Natl. Acad. Sci. U.S.A. 99, 4055-4060
69. Miller, V. M. and Duckles, S. P. (2008) Vascular actions of estrogens: functional implications. Pharmacol. Rev. 60, 210-241
70. Billon-Galés, A., Fontaine, C., Douin-Echinard, V., Delpy, L., Berges, H., Calippe, B., Lenfant, F., Laurell, H., Guéry, J. C., Gourdy, P. and Arnal, J. F. (2009) Endothelial estrogen receptor-α plays a crucial role in the atheroprotective action of 17β-estradiol in low-density lipoprotein receptor-deficient mice. Circulation 120, 2567-2576
71. Brouchet, L., Krust, A., Dupont, S., Chambon, P., Bayard, F. and Arnal, J. F. (2001) Estradiol accelerates reendothelialization in mouse carotid artery through estrogen receptor-α but not estrogen receptor-β. Circulation 103, 423-428
72. Hamada, H., Kim, M. K., Iwakura, A., Ii, M., Thorne, T., Qin, G., Asai, J., Tsutsumi, Y., Sekiguchi, H. and Silver, M. et al (2006) Estrogen receptors α and β mediate contribution of bone marrow-derived endothelial progenitor cells to functional recovery after myocardial infarction. Circulation. 114, 2261-2270
73. Nathan, L., Pervin, S., Singh, R., Rosenfeld, M. and Chaudhuri, G. (1999) Estradiol inhibits leukocyte adhesion and transendothelial migration in rabbits in vivo: possible mechanisms for gender differences in atherosclerosis. Circ. Res. 85, 377-385
74. Simoncini, T., Garibaldi, S., Fu, X. D., Pisaneschi, S., Begliuomini, S., Baldacci, C., Lenzi, E., Goglia, L., Giretti, M. S. and Genazzani, A. R. (2008) Effects of phytoestrogens derived from red clover on atherogenic adhesion molecules in human endothelial cells. Menopause 15, 542-550
75. Mukherjee, T. K., Nathan, L., Dinh, H., Reddy, S. T. and Chaudhuri, G. (2003) 17-Epiestriol, an estrogen metabolite, is more potent than estradiol in inhibiting vascular cell adhesion molecule 1 (VCAM-1) mRNA expression. J. Biol. Chem. 278, 11746-11752
76. Seli, E., Pehlivan, T., Selam, B., Garcia-Velasco, J. A. and Arici, A. (2002) Estradiol down-regulates MCP-1 expression in human coronary artery endothelial cells. Fertil. Steril. 77, 542-547
77. Murphy, H. S., Sun, Q., Murphy, B. A., Mo, R., Huo, J., Chen, J., Chensue, S. W., Adams, M., Richardson, B. C. and Yung, R. (2004) Tissue-specific effect of estradiol on endothelial cell-dependent lymphocyte recruitment. Microvasc. Res. 68, 273-285
78. Smith, L. H., Coats, S., Qin, H., Petrie, M. S., Covington, J. W., Su, M., Eren, M. and Vaughan, D. E. (2004) Differential and opposing regulation of PAI-1 promoter activity by estrogen receptor α and estrogen receptor β in endothelial cells. Circ. Res. 95, 269-275
79. Otsuki, M., Saito, H., Xu, X., Sumitani, S., Kouhara, H., Kishimoto, T. and Kasayama, S. (2001) Progesterone, but not medroxyprogesterone, inhibits vascular cell adhesion molecule-1 expression in human vascular endothelial cells. Arterioscler. Thromb. Vasc. Biol. 21, 243-248
80. Piercy, K. T., Donnell, R., Kirkpatrick, S. S., Timaran, C. H., Stevens, S. L., Freeman, M. B. andGoldman, M. H. (2002) Effects of estrogen, progesterone, and combination exposure on interleukin-1 β-induced expression of VCAM-1, ICAM-1, PECAM, and E-selectin by human female iliac artery endothelial cells. J. Surg. Res. 105, 215-219
81. Liu, J., Wu, S., Wei, H., Zhou, K., Ruan, Y. and Lai, W. (2002) Effects of sex hormones and their balance on the proliferation of rat vascular endothelial cells. Horm. Res. 58, 16-20
82. McCrohon, J. A., Jessup, W., Handelsman, D. J. and Celermajer, D. S. (1999) Androgen exposure increases human monocyte adhesion to vascular endothelium and endothelial cell expression of vascular cell adhesion molecule-1. Circulation 99, 2317-2322
83. Makela, S., Savolainen, H., Aavik, E., Myllarniemi, M., Strauss, L., Taskinen, E., Gustafsson, J. A. and Hayry, P. (1999) Differentiation between vasculoprotective and uterotrophic effects of ligands with different binding affinities to estrogen receptors α and β. Proc. Natl. Acad. Sci. U.S.A. 96, 7077-7082
84. Tsutsumi, S., Zhang, X., Takata, K., Takahashi, K., Karas, R. H., Kurachi, H. and Mendelsohn, M. E. (2008) Differential regulation of the inducible nitric oxide synthase gene by estrogen receptors 1 and 2. J. Endocrinol. 199, 267-273
85. Haas, E., Meyer, M. R., Schurr, U., Bhattacharya, I., Minotti, R., Nguyen, H. H., Heigl, A., Lachat, M., Genoni, M. and Barton, M. (2007) Differential effects of 17β-estradiol on function and expression of estrogen receptor α, estrogen receptor β, and GPR30 in arteries and veins of patients with atherosclerosis. Hypertension 49, 1358-1363
86. Lee, W. S., Harder, J. A., Yoshizumi, M., Lee, M. E. and Haber, E. (1997) Progesterone inhibits arterial smooth muscle cell proliferation. Nat. Med. 3, 1005-1008
87. Potier, M., Karl, M., Elliot, S. J., Striker, G. E. and Striker, L. J. (2003) Response to sex hormones differs in atherosclerosis-susceptible and -resistant mice. Am. J. Physiol. Endocrinol. Metab. 285, E1237-E1245
88. Nakamura, Y., Suzuki, T., Inoue, T., Tazawa, C., Ono, K., Moriya, T., Saito, H., Ishibashi, T., Takahashi, S., Yamada, S. and Sasano, H. (2005) Progesterone receptor subtypes in vascular smooth muscle cells of human aorta. Endocr. J. 52, 245-252
89. Fujimoto, R., Morimoto, I., Morita, E., Sugimoto, H., Ito, Y. and Eto, S. (1994) Androgen receptors, 5α-reductase activity and androgen-dependent proliferation of vascular smooth muscle cells. J. Steroid Biochem. Mol. Biol. 50, 169-174
90. Ling, S., Dai, A., Dilley, R. J., Jones, M., Simpson, E., Komesaroff, P. A. and Sudhir, K. (2004) Endogenous estrogen deficiency reduces proliferation and enhances apoptosis-related death in vascular smooth muscle cells: insights from the aromatase-knockout mouse. Circulation 109, 537-543
91. Iafrati, M. D., Karas, R. H., Aronovitz, M., Kim, S., Sullivan, Jr, T. R., Lubahn, D. B., O'Donnell, Jr, T. F., Korach, K. S. and Mendelsohn, M. E. (1997) Estrogen inhibits the vascular injury response in estrogen receptor α-deficient mice. Nat. Med. 3, 545-548
92. Karas, R. H., Hodgin, J. B., Kwoun, M., Krege, J. H., Aronovitz, M., Mackey, W., Gustafsson, J. A., Korach, K. S., Smithies, O. and Mendelsohn, M. E. (1999) Estrogen inhibits the vascular injury response in estrogen receptor β-deficient female mice. Proc. Natl. Acad. Sci. U.S.A. 96, 15133-15136
93. Karas, R. H., Schulten, H., Pare, G., Aronovitz, M. J., Ohlsson, C., Gustafsson, J. A. and Mendelsohn, M. E. (2001) Effects of estrogen on the vascular injury response in estrogen receptor α, β (double) knockout mice. Circ. Res. 89, 534-539
94. Kawagoe, J., Ohmichi, M., Tsutsumi, S., Ohta, T., Takahashi, K. and Kurachi, H. (2007) Mechanism of the divergent effects of estrogen on the cell proliferation of human umbilical endothelial versus aortic smooth muscle cells. Endocrinology 148, 6092-6099
95. Antoniucci, D., Miller, V. M., Sieck, G. C. and Fitzpatrick, L. A. (2001) Gender-related differences in proliferative responses of vascular smooth muscle cells to endothelin-1. Endothelium 8, 137-145
96. Strehlow, K., Rotter, S., Wassmann, S., Adam, O., Grohé, C., Laufs, K., Böhm, M. and Nickenig, G. (2003) Modulation of antioxidant enzyme expression and function by estrogen. Circ. Res. 93, 170-177
97. Wassmann, K., Wassmann, S. and Nickenig, G. (2005) Progesterone antagonizes the vasoprotective effect of estrogen on antioxidant enzyme expression and function. Circ. Res. 97, 1046-1054
98. Dubey, R. K., Gillespie, D., Grögli, M., Kloosterboer, H. J. and Imthurn, B. (2004) Tibolone and its metabolites induce antimitogenesis in human coronary artery smooth muscle cells: role of estrogen, progesterone, and androgen receptors. J. Clin. Endocrinol. Metab. 89, 852-859
99. Karas, R. H., van Eickels, M., Lydon., J. P., Roddy, S., Kwoun, M., Aronovitz, M., Baur, W. E., Conneely, O., O'Malley, B. W. and Mendelsohn, M. E. (2001) A complex role for the progesterone receptor in the response to vascular injury. J. Clin. Invest. 108, 611-618
100. Hanke, H., Hanke, S., Finking, G., Muhic-Lohrer, A., Muck, A. O., Schmahl, F. W., Haasis, R. and Hombach, V. (1996) Different effects of estrogen and progesterone on experimental atherosclerosis in female versus male rabbits. Quantification of cellular proliferation by bromodeoxyuridine Circulation 94, 175-181
101. Nickenig, G., Strehlow, K., Wassmann, S., Baumer, A. T., Albory, K., Sauer, H. and Bohm, M. (2000) Differential effects of estrogen and progesterone on AT1 receptor gene expression in vascular smooth muscle cells. Circulation 102, 1828-1833
102. Williams, M. R., Ling, S., Dawood, T., Hashimura, K., Dai, A., Li, H., Liu, J. P., Funder, J. W., Sudhir, K. and Komesaroff, P. A. (2002) Dehydroepiandrosterone inhibits human vascular smooth muscle cell proliferation independent of ARs and ERs. J. Clin. Endocrinol. Metab. 87, 176-181
103. Bowles, D. K., Maddali, K., Dhulipala, V. C. and Korzick, D. H. (2007) PKCδ mediates anti-proliferative, pro-apoptic effects of testosterone on coronary smooth muscle. Am. J. Physiol. Cell Physiol. 293, C805-C8013
104. Bonnet, S., Paulin, R., Sutendra, G., Dromparis, P., Roy, M., Watson, K. O., Nagendran, J., Haromy, A., Dyck, J. R. and Michelakis, E. D. (2009) Dehydroepiandrosterone reverses systemic vascular remodeling through the inhibition of the Akt/GSK3β/NFAT axis. Circulation 120, 1231-1240
105. Higashiura, K., Mathur, R. S. and Halushka, P. V. (1997) Gender-related differences in androgen regulation of thromboxane A2 receptors in rat aortic smooth-muscle cells. J. Cardiovasc. Pharmacol. 29, 311-315
106. Murphy, A. J., Guyre, P. M., Wira, C. R. and Pioli, P. A. (2009) Estradiol regulates expression of estrogen receptor ERα46 in human macrophages. PLoS ONE 4, e5539
107. Barish, G. D., Downes, M., Alaynick, W. A., Yu, R. T., Ocampo, C. B., Bookout, A. L., Mangelsdorf, D. J. and Evans, R. M. (2005) A nuclear receptor atlas: macrophage activation. Mol. Endocrinol. 19, 2466-2477
108. Schust, D. J., Anderson, D. J. and Hill, J. A. (1996) Progesterone-induced immunosuppression is not mediated through the progesterone receptor. Hum. Reprod. 11, 980-985
109. Blasko, E., Haskell, C. A., Leung, S., Gualtieri, G., Halks-Miller, M., Mahmoudi, M., Dennis, M. K., Prossnitz, E. R., Karpus, W. J. and Horuk, R. (2009) Beneficial role of the GPR30 agonist G-1 in an animal model of multiple sclerosis. J. Neuroimmunol. 214, 67-77
110. McLaren, J., Prentice, A., Charnock-Jones, D. S., Millican, S. A., Müller, K. H., Sharkey, A. M. and Smith, S. K. (1996) Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids. J. Clin. Invest. 98, 482-489
111. Sader, M. A., McGrath, K., Hill, M. D., Bradstock, K. F., Jimenez, M., Handelsman, D. J., Celermajer, D. S. and Death, A. K. (2005) Androgen receptor gene expression in leucocytes is hormonally regulated: implications for gender differences in disease pathogenesis. Clin. Endocrinol. 62, 56-63
112. Brechenmacher, S. A., Bruns, C., Van den Engel, N. K., Angele, P., Loehe, F., Jauch, K. W. and Angele, M. K. (2008) Influence of surgical trauma on the mRNA expression of sex hormone receptors in PBMCs in male and female patients. Langenbecks Arch. Surg. 393, 871-876
113. McCrohon, J. A., Death, A. K., Nakhla, S., Jessup, W., Handelsman, D. J., Stanley, K. K. and and Celermajer, D. S. (2000) Androgen receptor expression is greater in macrophages from male than from female donors: a sex difference with implications for atherogenesis. Circulation 101, 224-226
114. Ashcroft, G. S. and Mills, S. J. (2002) Androgen receptor-mediated inhibition of cutaneous wound healing. J. Clin. Invest. 110, 615-624
115. Lai, J. J., Lai, K. P., Chuang, K. H., Chang, P., Yu, I. C., Lin, W. J. and Chang, C. (2009) Monocyte/macrophage androgen receptor suppresses cutaneous wound healing in mice by enhancing local TNF-α expression. J. Clin. Invest. 119, 3739-3751
116. Frazier-Jessen, M. R. and Kovacs, E. J. (1995) Estrogen modulation of JE/monocyte chemoattractant protein-1 mRNA expression in murine macrophages. J. Immunol. 154, 1838-1845
117. Deshpande, R., Khalili, H., Pergolizzi, R. G., Michael, S. D. and Chang, M. D. (1997) Estradiol down-regulates LPS-induced cytokine production and NFκB activation in murine macrophages. Am. J. Reprod. Immunol. 38, 46-54
118. Biswas, D. K., Singh, S., Shi, Q., Pardee, A. B. and Iglehart, J. D. (2005) Crossroads of estrogen receptor and NF-κB signaling. Sci. STKE 2005, pe27
119. Huang, H., He, J., Yuan, Y., Aoyagi, E., Takenaka, H., Itagaki, T., Sannomiya, K., Tamaki, K., Harada, N., Shono, M., Shimizu, I. and Takayama, T. (2008) Opposing effects of estradiol and progesterone on the oxidative stress-induced production of chemokine and proinflammatory cytokines in murine peritoneal macrophages. J. Med. Invest. 55, 133-141
120. Liu, J., Wu, S., Wei, H., Zhou, K., Ruan, Y. and Lai, W. (2002) Effects of sex hormones and their balance on the proliferation of rat vascular endothelial cells. Horm. Res. 58, 16-20
121. Luksha, L. and Kublickiene, K. (2009) The role of estrogen receptor subtypes for vascular maintenance. Gynecol. Endocrinol. 25, 82-95
122. Sheshgiri, R., Rao, V., Tumiati, L. C., Xiao, R., Prodger, J. L., Badiwala, M., Librach, C. and Delgado, D. H. (2008) Progesterone induces human leukocyte antigen-g expression in vascular endothelial and smooth muscle cells. Circulation 118, S58-S64
123. Kramer, P. R., Winger, V. and Kramer, S. F. (2007) 17β Estradial utilized the estrogen receptor to regulate CD16 expression in monocytes. Mol. Cell. Endocrinol. 279, 16-25
124. Murphy, A. J., Guyre, P. M., Wira, C. R. and Pioli, P. A. (2009) Estradiol regulates expression of estrogen receptor ERα46 in human macrophages. PLoS ONE 4, e5539
125. Rettew, J. A., Huet-Hudson, Y. and Marriott, I. (2008) Testosterone reduces macrophage expression in the mouse of Toll-like receptor 4, a trigger for inflammation and innate immunity. Biol. Reprod. 78, 432-437
126. Rettew, J. A., Huet, Y. M. and Marriott, I. (2009) Estrogens augment cell surface TLR4 expression on murine macrophages and regulate sepsis susceptibility in vivo. Endocrinology 150, 3877-3884
127. Butler, J. D., Blanchette-Mackie, J., Goldin, E., O'Neill, R. R., Carstea, G., Roff, C. F., Patterson, M. C., Patel, S., Comly, M. E., Cooney, A. et al. (1992) Progesterone blocks cholesterol translocation from lysosomes. J. Biol. Chem. 267, 23797-23805
128. Wilson, M. E., Sengoku, T. and AllredK., F. (2008) Estrogen prevents cholesteryl ester accumulation in macrophages induced by the HIV protease inhibitor ritonavir. J. Cell. Biochem. 103, 1598-1606
129. Badeau, R. M., Metso, J., Wahala, K., Tikkanen, M. J. and Jauhiainen, M. (2009) Human macrophage cholesterol efflux potential is enhanced by HDL-associated 17β-estradiol fatty acyl esters. J. Steroid Biochem. Mol. Biol. 116, 44-49
130. Ng, M. K., Jessup, W. and Celermajer, D. S. (2001) Sex-related differences in the regulation of macrophage cholesterol metabolism. Curr. Opin. Lipidol. 12, 505-510
131. Evans, M. J., Eckert, A., Lai, K., Adelman, S. J. and Harnish, D. C. (2001) Reciprocal antagonism between estrogen receptor and NF-κB activity in vivo. Circ. Res.. 89, 823-830
132. Chu, S., Nishi, Y., Yanase, T., Nawata, H. and Fuller, P. J. (2004) Transrepression of estrogen receptor β signaling by nuclear factor-κB in ovarian granulosa cells. Mol. Endocrinol. 18, 1919-1928
133. Merz, C. N., Johnson, B. D., Berga, S. L., Braunstein, G. D., Azziz, R., Yang, Y., Reis, S. E., Bittner, V., Hodgson, T. K., Pepine, C. J. et al. (2009) Total estrogen time and obstructive coronary disease in women: insights from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE). J. Womens Health 18, 1315-1322
134. Turgeon, J. L., Carr, M. C., Maki, P. M., Mendelsohn, M. E. and Wise, P. M. (2006) Complex actions of sex steroids in adipose tissue, the cardiovascular system, and brain: insights from basic science and clinical studies. Endocr. Rev. 27, 575-605
135. Clarkson, T. B. and Karas, R. H. (2007) Do the cardiovascular disease risks and benefits of oral versus transdermal estrogen therapy differ between perimenopausal and postmenopausal women? Menopause 14, 963-967
136. Manson, J. E. and Bassuk, S. S. (2007) Hormone therapy and risk of coronary heart disease why renew the focus on the early years of menopause? Am. J. Epidemiol. 166, 511-517
137. Bourassa, P. A., Milos, P. M., Gaynor, B. J., Breslow, J. L. and Aiello, R. J. (1996) Estrogen reduces atherosclerotic lesion development in apolipoprotein E-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 93, 10022-10027
138. Elhage, R., Arnal, J. F., Pieraggi, M. T., Duverger, N., Fievet, C., Faye, J. C. and Bayard, F. (1997) 17β-Estradiol prevents fatty streak formation in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 17, 2679-2684
139. Marsh, M. M., Walker, V. R., Curtiss, L. K. and Banka, C. L. (1999) Protection against atherosclerosis by estrogen is independent of plasma cholesterol levels in LDL receptor-deficient mice. J. Lipid Res. 40, 893-900
140. -/- mice. J. Clin. Invest. 107, 333-340
141. Hanke, H., Kamenz, J., Hanke, S., Spiess, J., Lenz, C., Brehme, U., Bruck, B., Finking, G. and Hombach, V. (1999) Effect of 17-β estradiol on pre-existing atherosclerotic lesions: role of the endothelium. Atherosclerosis 147, 123-132
142. Villablanca, A. C., Tenwolde, A., Lee, M., Huck, M., Mumenthaler, S. and Rutledge, J. C. (2009) 17β-Estradiol prevents early-stage atherosclerosis in estrogen receptor-α deficient female mice. J. Cardiovasc. Transl. Res. 2, 289-299
143. Hodgin, J. B. and Maeda, N. (2002) Minireview: estrogen and mouse models of atherosclerosis. Endocrinology 143, 4495-4501
144. Miller, H., Poon, S., Hibbert, B., Rayner, K., Chen, Y. X. and O'Brien, E. R. (2005) Modulation of estrogen signaling by the novel interaction of heat shock protein 27, a biomarker for atherosclerosis, and estrogen receptor β: mechanistic insight into the vascular effects of estrogens. Arterioscler. Thromb. Vasc. Biol. 25, e10-e14
145. Christian, R. C., Liu, P. Y., Harrington, S., Ruan, M., Miller, V. M. and Fitzpatrick, L. A. (2006) Intimal estrogen receptor (ER)β, but not ERα expression, is correlated with coronary calcification and atherosclerosis in pre- and postmenopausal women. J. Clin. Endocrinol. Metab. 91, 2713-2720
146. Dubey, R. K., Jackson, E. K., Gillespie, D. G., Zacharia, L. C. and Imthurn, B. (2004) Catecholamines block the antimitogenic effect of estradiol on human coronary artery smooth muscle cells. J. Clin. Endocrinol. Metab. 89, 3922-3931
147. Hodges, Y. K., Richer, J. K., Horwitz, K. B. and Horwitz, L. D. (1999) Variant estrogen and progesterone receptor messages in human vascular smooth muscle. Circulation 99, 2688-2693
148. Phillips, L. S. and Langer, R. D. (2005) Postmenopausal hormone therapy: critical reappraisal and a unified hypothesis. Fertil. Steril. 83, 558-566
149. Ferri, N., Paoletti, R. and Corsini, A. (2006) Biomarkers for atherosclerosis: pathophysiological role and pharmacological modulation. Curr. Opin. Lipidol. 17, 495-501
150. Koenig, W. and Khuseyinova, N. (2007) Biomarkers of atherosclerotic plaque instability and rupture. Arterioscler. Thromb. Vasc. Biol. 27, 15-26
151. Rohatgi, A., Owens, A. W., Khera, A., Colby, R., Ayers, K. B., Das, S. R., Berry, J. D., McGuire, D. K. and De Lemos, J. A. (2009) Differential associations between soluble cellular adhesion molecules and atherosclerosis in the dallas Heart Study: a distinct role for soluble endothelial cell-selective adhesion molecule. Arterioscler. Thromb. Vasc. Biol. 29, 1684-1690
152. Kampoli, A. M., Tousoulis, D., Antoniades, C., Siasos, G. and and Stefanadis, C. (2009) Biomarkers of premature atherosclerosis. Trends Mol. Med. 15, 323-332
153. Leung, J., Jayachandran, M., Kendall-Thomas, J., Behrenbeck, T., Araoz, P. A. and Miller, V. M. (2008) Pilot study of sex differences in chemokine/cytokine markers of atherosclerosis in humans. Gender Med. 5, 44-52
154. Vivanco, F., Padial, L. R., Darde, V. M., de la Cuesta, F., Alvarez-Llamas, G., Diaz-Prieto, N. and Barderas, M. G. (2008) Proteomic biomarkers of atherosclerosis. Biomarker Insights 3, 101-113
155. López-Pedrera, C., Barbarroja, N. and Villalba, J. M. (2009) Novel biomarkers of atherosclerosis and cardiovascular risk in autoimmune diseases: genomics and proteomics approaches. Proteomics Clin. Appl. 3, 213-225
156. Revkin, J. H., Shear, C. L., Pouleur, H. G., Ryder, S. W. and Orloff, D. G. (2007) Biomarkers in the prevention and treatment of atherosclerosis: need, validation, and future. Pharmacol. Rev. 59, 40-53
157. Babuin, L. and Jaffe, S. A. (2005) Troponin: the biomarker of choice for the detection of cardiac injury. CMAJ 173, 1191-1202
158. McDermott, M. M. and Lloyd-Jones, D. M. (2009) The role of biomarkers and genetics in peripheral arterial disease. J. Am. Coll. Cardiol. 54, 1228-1237
159. Miller, V. M., Redfield, M. M. and McConnell, J. P. (2007) Use of BNP and CRP as biomarkers in assessing cardiovascular disease: diagnosis versus risk. Curr. Vasc. Pharmacol. 5, 15-25
160. Vasan, R. S. (2006) Biomarkers of cardiovascular disease: molecular basis and practical considerations. Circulation 113, 2335-2362
161. Esmon, C. T. (2009) Basic mechanisms and pathogenesis of venous thrombosis. Blood Rev. 23, 225-229
162. Miller, V. M., Hunter, L. W., Chu, K., Kaul, V., Squillace, P. D., Lieske, J. C. and Jayachandran, M. (2009) Biologic nanoparticles and platelet reactivity. Nanomedicine 4, 725-733
163. Kakizawa, Y., Nishio, R., Hirano, T., Koshi, Y., Nukiwa, M., Koiwa, M., Michizoe, J. and Ida, N. (2010) Controlled release of protein drugs from newly developed amphiphilic polymer-based microparticles composed of nanoparticles. J. Control. Release 142, 8-13
164. Schwartz, M.-K., Lieske, JC., Kumar, V., Farell-Baril, G. and Miller, VM. (2008) Human-derived nanoparticles and vascular responses to injury in rabbit carotid arteries: proof of principle. Int. J. Nanomed. 3, 243-248
165. Martel, J. and Young, J. D. (2008) Purported nanobacteria in human blood as calcium carbonate nanoparticles. Proc. Natl. Acad. Sci. U.S.A. 105, 5549-5554
166. Zwaal, R. F. and Schroit, A. J. (1997) Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 89, 1121-1132
167. VanWijk, M. J., VanBavel, E., Sturk, A. and Nieuwland, R. (2003) Microparticles in cardiovascular diseases. Cardiovasc. Res. 59, 277-287
168. Morel, O., Toti, F., Hugel, B., Bakouboula, B., Camoin-Jau, L., Dignat-George, F. and Freyssinet, J. M. (2006) Procoagulant microparticles: disrupting the vascular homeostasis equation? Arterioscler. Thromb. Vasc. Biol. 26, 2594-2604
169. Blann, A., Shantsila, E. and Shantsila, A. (2009) Microparticles and arterial disease. Semin. Thromb. Hemostasis 35, 488-496
170. Pericleous, C., Giles, I. and Rahman, A. (2009) Are endothelial microparticles potential markers of vascular dysfunction in the antiphospholipid syndrome? Lupus 18, 671-675
171. Leroyer, A. S., Tedgui, A. and Boulanger, C. M. (2008) Role of microparticles in atherothrombosis. J. Intern. Med. 263, 528-537
172. Chironi, G. N., Boulanger, C. M., Simon, A., Dignat-George, F., Freyssinet, J. M. and Tedgui, A. (2009) Endothelial microparticles in diseases. Cell Tissue Res. 335, 143-151
173. Flores-Nascimento, M. C., Beltrame, M. P., De Paula, E. V., Montalvao, S. L., Pereira, F. G., Orsi, F. L., Lorand-Metze, I. and Annichino-Bizzacchi, J. M. (2009) Microparticles in deep venous thrombosis, antiphospholipid syndrome and Factor V Leiden. Platelets 20, 367-375
174. Piccin, A., Murphy, W. G. and Smith, O. P. (2007) Circulating microparticles: pathophysiology and clinical implications. Blood Rev. 21, 157-171
175. Mause, S. F., von Hundelshausen, P., Zernecke, A., Koenen, R. R. and Weber, C. (2005) Platelet microparticles: a transcellular delivery system for RANTES promoting monocyte recruitment on endothelium. Arterioscler. Thromb. Vasc. Biol. 25, 1512-1518
176. Deregibus, M. C., Cantaluppi, V., Calogero, R., Lo Iacono, M., Tetta, C., Biancone, L., Bruno, S., Bussolati, B. and Camussi, G. (2007) Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. Blood 110, 2440-2448
177. Amabile, N., Guerin, A. P., Leroyer, A., Mallat, Z., Nguyen, C., Boddaert, J., London, G. M., Tedgui, A. and Boulanger, C. M. (2005) Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. J. Am. Soc. Nephrol. 16, 3381-3388
178. Boulanger, C. M., Scoazec, A., Ebrahimian, T., Henry, P., Mathieu, E., Tedgui, A. and Mallat, Z. (2001) Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation 104, 2649-2652
179. VanWijk, M. J., Nieuwland, R., Boer, K., van der Post, J. A., VanBavel, E. and Sturk, A. (2002) Microparticle subpopulations are increased in preeclampsia: possible involvement in vascular dysfunction? Am. J. Obstet. Gynecol. 187, 450-456
180. Kolodgie, F. D., Narula, J., Haider, N. and Virmani, R. (2001) Apoptosis in atherosclerosis. Does it contribute to plaque instability? Cardiol. Clin. 19, 127-139
181. Walsh, K., Smith, R. C. and Kim, H. S. (2000) Vascular cell apoptosis in remodeling, restenosis, and plaque rupture. Circ. Res. 87, 184-188
182. Jimenez, J. J., Jy, W., Mauro, L. M., Soderland, C., Horstman, L. L. and Ahn, Y. S. (2003) Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. Thromb. Res. 109, 175-180
183. Coleman, M. L., Sahai, E. A., Yeo, M., Bosch, M., Dewar, A. and Olson, M. F. (2001) Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I. Nat. Cell Biol. 3, 339-345
184. Kockx, M. M. (1998) Apoptosis in the atherosclerotic plaque. Quantitative and qualitative aspects. Arterioscler. Thromb. Vasc. Biol. 18, 1519-1522
185. Mallat, Z., Hugel, B., Ohan, J., Leseche, G., Freyssinet, J. M. and Tedgui, A. (1999) Shed membrane microparticles with procoagulant potential in human atherosclerotir plaques: a role for apoptosis in plaque thrombogenicity. Circulation 99, 348-353
186. Leroyer, A. S., Isobe, H., Leseche, G., Castier, Y., Wassef, M., Mallat, Z., Binder, B. R., Tedgui, A. and Boulanger, C. M. (2007) Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques. J. Am. Coll. Cardiol. 49, 772-777
187. Jayachandran, M., Litwiller, R. D., Owen, W. G., Heit, J. A., Behrenbeck, T. R., Mulvagh, S. L., Araoz, P. A., Budoff, M. J., Harman, S. M. and Miller, V. M. (2008) Characterization of blood borne microparticles as markers of premature coronary calcification in recently menopausal women. Am. J. Physiol. Heart Circ. Physiol. 295, H931-H938
188. Jayachandran, M., Litwiller, R. D., Owen, W. G. and Miller, V. M. (2009) Circulating microparticles and endogenous estrogen in newly menopausal women. Climacteric 12, 1-8
189. Jayachandran, M., Preston, C. C., Hunter, L. W., Jahangir, A., Owen, W. G., Korach, K. S. and Miller, V. M. (2010) Loss of estrogen receptor β decreases mitochondrial energetic potential and increases thrombogenicity of platelets in aged female mice. Age 32, 109-121
190. Fitzpatrick, L. A. (1999) Selective estrogen receptor modulators and phytoestrogens: new therapies for the postmenopausal women. Mayo Clin. Proc. 74, 601-607
191. Roe, E. B., Chiu, K. M. and Arnaud, C. D. (2000) Selective estrogen receptor modulators and postmenopausal health. Adv. Intern. Med. 45, 259-278
192. Glazier, M. G. and Bowman, M. A. (2001) A review of the evidence for the use of phytoestrogens as a replacement for traditional estrogen replacement therapy. Arch. Intern. Med. 161, 1161-1172
193. Nandur, R., Kumar, K. and Villablanca, A. C. (2004) Cardiovascular actions of selective estrogen receptor modulators (SERMS) and phytoestrogens. Prev. Cardiol. 7, 73-79
194. Obendorf, M. and Patchev, V. K. (2004) Interactions of sex steroids with mechanisms of inflammation. Curr. Drug Targets Inflamm. Allergy 3, 425-433
195. Paavonen, T., Andersson, L. C. and Adlercreutz, H. (1981) Sex hormone regulation of in vitro immune response. Estradiol enhances human B cell maturation via inhibition of suppressor T cells in pokeweed mitogen-stimulated cultures. J. Exp. Med. 154, 1935-1945
196. Stork, S., Baumann, K., von Schacky, C. and Angerer, P. (2002) The effect of 17 β-estradiol on MCP-1 serum levels in postmenopausal women. Cardiovasc. Res. 53, 642-649
197. Nilsson, B. O. (2007) Modulation of the inflammatory response by estrogens with focus on the endothelium and its interactions with leukocytes. Inflamm. Res. 56, 269-273
198. Asai, K., Hiki, N., Mimura, Y., Ogawa, T., Unou, K. and Kaminishi, M. (2001) Gender differences in cytokine secretion by human peripheral blood mononuclear cells: role of estrogen in modulating LPS-induced cytokine secretion in an ex vivo septic model. Shock 16, 340-343
199. Ghisletti, S., Meda, C., Maggi, A. and Vegeto, E. (2005) 17β-Estradiol inhibits inflammatory gene expression by controlling NF-κB intracellular localization. Mol. Cell. Biol. 25, 2957-2968
200. McKay, L. I. and Cidlowski, J. A. (1999) Molecular control of immune/inflammatory responses: interactions between nuclear factor-κB and steroid receptor-signaling pathways. Endocr. Rev. 20, 435-459
201. Zang, Y. C., Halder, J. B., Hong, J., Rivera, V. M. and Zhang, J. Z. (2002) Regulatory effects of estriol on T cell migration and cytokine profile: inhibition of transcription factor NF-κB. J. Neuroimmunol. 124, 106-114
202. Calippe, B., Douin-Echinard, V., Laffargue, M., Laurell, H., Rana-Poussine, V., Pipy, B., Guery, J. C., Bayard, F., Arnal, J. F. and Gourdy, P. (2008) Chronic estradiol administration in vivo promotes the proinflammatory response of macrophages to TLR4 activation: involvement of the phosphatidylinositol 3-kinase pathway. J. Immunol. 180, 7980-7988
203. Zhang, Q., Raoof, M., Chen, Y., Sumi, Y., Sursal, T., Junger, W., Brohi, K., Itagaki, K. and Hauser, C. J. (2010) Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 464, 104-107
204. Feldman, R. D. and Gros, R. (2010) Rapid vascular effects of steroids: a question of balance? Can. J. Cardiol. 26 (Suppl. A), 22A-26A
205. Langer, G., Bader, B., Meoli, L., Isensee, J., Delbeck, M., Noppinger, P. R. and Otto, C. (2010) A critical review of fundamental controversies in the field of GPR30 research. Steroids 75, 603-610
206. Mizukami, Y. (2010) In vivo functions of GPR30/GPER-1, a membrane receptor for estrogen: from discovery to functions in vivo. Endocr. J. 57, 101-107
207. Olde, B. and Leeb-Lundberg, L. M. (2009) GPR30/GPER1: searching for a role in estrogen physiology. Trends Endocrinol. Metab. 20, 409-416
208. Prossnitz, E. R. and Barton, M. (2009) Signaling, physiological functions and clinical relevance of the G protein-coupled estrogen receptor GPER. Prostaglandins Other Lipid Mediat. 89, 89-97